THE TMPRSS2:ERG REARRANGEMENT, ERG EXPRESSION, AND PROSTATE CANCER OUTCOMES: A COHORT STUDY AND META-ANALYSIS

BACKGROUND: Whether the genomic rearrangement TMPRSS2:ERG has prognostic value in prostate cancer is unclear. METHODS: Among men with prostate cancer in the prospective Physicians’ Health and Health Professionals Follow-Up Studies, we identified rearrangement status by immunohistochemical assessment...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Pettersson, Andreas, Graff, Rebecca E., Bauer, Scott R., Pitt, Michael, Lis, Rosina T., Stack, Edward C., Martin, Neil E., Kunz, Lauren, Penney, Kathryn L., Ligon, Azra H., Suppan, Catherine, Flavin, Richard, Sesso, Howard D., Rider, Jennifer R., Sweeney, Christopher, Stampfer, Meir, Fiorentino, Michelangelo, Kantoff, Philip W., Sanda, Martin, Giovannucci, Edward, Ding, Eric L., Loda, Massimo, Mucci, Lorelei A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671609/
https://ncbi.nlm.nih.gov/pubmed/22736790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-12-0042
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller